BS
Bonstein Sara Chief Financial Officer
Other F
Insider track record CFO Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Bonstein Sara, Chief Financial Officer. Officer active across 4 companies, notably INSMED Inc. Aggregated, 29 filings have been logged. Split: 0 buy · 13 sells. Total volume traded: €5.4m. History available since 11 January 2022. The latest transaction was filed on 13 May 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations 29 total
▼ Chief Financial Officer · Executives · 13 May 2026 · INSMED Inc 8,272 shares @ US$116.18 0.0022% mcap 97.0% of flow Common Stock SEC:0001604019-26-000008
▼ Chief Financial Officer · Executives · 13 May 2026 · INSMED Inc 8,272 shares @ US$116.18 0.0022% mcap 94.1% of flow Common Stock SEC:0001604019-26-000008:0
◆ Chief Financial Officer · Executives · 15 May 2025 · INSMED Inc 6,508 shares 0Common Stock SEC:0001628280-25-026586:0
▼ Chief Financial Officer · Executives · 13 May 2025 · INSMED Inc 8,870 shares @ US$67.81 14.2% of flow Common Stock SEC:0001628280-25-025980:0
▼ Chief Financial Officer · Executives · 18 Feb 2025 · INSMED Inc 17,622 shares @ US$80.28 35.5% of flow Common Stock SEC:0001628280-25-006804:0
▼ Chief Financial Officer · Executives · 11 Feb 2025 · INSMED Inc 13,302 shares @ US$80.00 27.2% of flow Common Stock SEC:0001628280-25-005465:0
◆ Chief Financial Officer · Executives · 5 Feb 2025 · INSMED Inc 65,033 shares 0Common Stock SEC:0001628280-25-004459:0
▼ Chief Financial Officer · Executives · 7 Jan 2025 · INSMED Inc 3,470 shares @ US$65.70 5.8% of flow Common Stock SEC:0001628280-25-001206:0
◇ Chief Financial Officer · Executives · 28 May 2024 · INSMED Inc 3,454 shares @ US$28.88 2.4% of flow Common Stock SEC:0001628280-24-025886:0
◆ Chief Financial Officer · Executives · 13 May 2024 · INSMED Inc 14,518 shares Common Stock SEC:0001628280-24-023591:0
▼ Chief Financial Officer · Executives · 9 Jan 2024 · INSMED Inc 4,497 shares @ US$29.18 3.2% of flow Common Stock SEC:0001628280-24-001160:0
◆ Chief Financial Officer · Executives · 4 Jan 2024 · INSMED Inc 12,873 shares Common Stock SEC:0001628280-24-000691:0
▼ Chief Financial Officer · Executives · 22 Dec 2023 · INSMED Inc 13,199 shares @ US$30.00 9.5% of flow Common Stock SEC:0001628280-23-042628:0
▼ Chief Financial Officer · Executives · 15 May 2023 · INSMED Inc 2,210 shares @ US$19.30 1.0% of flow Common Stock SEC:0001628280-23-018679:0
◆ Chief Financial Officer · Executives · 11 May 2023 · INSMED Inc 34,300 shares Common Stock SEC:0001628280-23-018160:0
▼ Chief Financial Officer · Executives · 10 Jan 2023 · INSMED Inc 2,857 shares @ US$18.12 1.3% of flow Common Stock SEC:0001628280-23-000958:0
◆ Chief Financial Officer · Executives · 5 Jan 2023 · INSMED Inc 8,232 shares Common Stock SEC:0001628280-23-000632:0
▼ Chief Financial Officer · Executives · 16 May 2022 · INSMED Inc 1,433 shares @ US$18.51 0.0001% mcap 2.9% of flow Common Stock SEC:0001140361-22-019783:0
◆ Chief Financial Officer · Executives · 11 May 2022 · INSMED Inc 20,137 shares Common Stock SEC:0001140361-22-019172:0
▼ Chief Financial Officer · Executives · 11 Jan 2022 · INSMED Inc 1,154 shares @ US$25.11 0.0001% mcap 3.0% of flow Common Stock SEC:0001140361-22-001602
▼ Chief Financial Officer · Executives · 11 Jan 2022 · INSMED Inc 1,154 shares @ US$25.11 0.0001% mcap 2.9% of flow Common Stock SEC:0001140361-22-001602:0
◆ Chief Financial Officer · Executives · 6 Jan 2022 · INSMED Inc 13,006 shares Common Stock SEC:0001140361-22-001165
◆ Chief Financial Officer · Executives · 6 Jan 2022 · INSMED Inc 13,006 shares Common Stock SEC:0001140361-22-001165:0
◆ Chief Financial Officer · Executives · 12 May 2021 · INSMED Inc 14,172 shares Common Stock SEC:0001140361-21-017464:0
◆ Chief Financial Officer · Executives · 12 May 2021 · INSMED Inc 14,172 shares Common Stock SEC:0001140361-21-017464
25 of 29 declarations
Load more (4 remaining) About Bonstein Sara Sara Bonstein is the Chief Financial Officer at INSMED Inc. She is responsible for the company's financial management, including financial planning and analysis. Bonstein plays a crucial role in developing financial strategies that support INSMED's objectives. Her expertise in finance and accounting is essential for ensuring the company's financial health.